CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 7 of the 33 sources its claims cite were checked for support.

Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age

Open access

Abstract

Objective: To compare body composition and metabolic outcomes at 7–9 years in offspring of women with gestational diabetes (GDM) randomized to metformin (±insulin) or insulin treatment during pregnancy. Research design and methods: Children were assessed at 7 years in Adelaide (n=109/181) and 9 years in Auckland (n=99/396) by anthropometry, bioimpedance analysis (BIA), dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI) (n=92/99) and fasting bloods (n=82/99). Results: In the Adelaide subgroup, mothers were similar at enrollment. Women randomized to metformin versus insulin had higher treatment glycemia (p=0.002) and more infants with birth weight >90th percentile (20.7% vs 5.9%; p=0.029). At 7 years, there were no differences in offspring measures. In Auckland, at enrollment, women randomized to metformin had a higher body mass index (BMI) (p=0.08) but gained less weight during treatment (p=0.07). Offspring birth measures were similar. At 9 years, metformin offspring were larger by measures of weight, arm and waist circumferences, waist:height (p<0.05); BMI, triceps skinfold (p=0.05); DXA fat mass and lean mass (p=0.07); MRI abdominal fat volume (p=0.051). Body fat percent was similar between treatment groups by DXA and BIA. Abdominal fat percentages (visceral adipose tissue, subcutaneous adipose tissue and liver) were similar by MRI. Fasting glucose, triglyceride, insulin, insulin resistance, glycosylated hemoglobin (HbA1c), cholesterol, liver transaminases, leptin and adiponectin were similar. Conclusions: Metformin or insulin for GDM was associated with similar offspring total and abdominal body fat percent and metabolic measures at 7–9 years. Metformin-exposed children were larger at 9 years. Metformin may interact with fetal environmental factors to influence offspring outcomes.

Overview

CoChat Summary

TL;DR

In offspring of women with gestational diabetes randomized to metformin (±insulin) versus insulin, total and abdominal body fat percent and metabolic measures were similar at 7–9 years. Metformin-exposed children in the Auckland 9-year subgroup were larger on several anthropometric and fat-mass measures.

Key findings

  • In the Adelaide 7-year subgroup, offspring body composition measures did not differ between treatment arms; mothers randomized to metformin had higher treatment glycemia (p=0.002) and more infants with birth weight >90th percentile (20.7% vs 5.9%; p=0.029).
  • In the Auckland 9-year subgroup, metformin offspring were larger by weight (37.0±12.6 vs 32.7±7.7 kg; p=0.049), mid-upper arm circumference (23.0±4.3 vs 21.2±2.9 cm; p=0.02), waist circumference (69.1±12.2 vs 64.2±8.4 cm; p=0.04), and waist:height ratio (0.51±0.08 vs 0.47±0.05; p=0.02); BMI and triceps skinfold were borderline (p=0.051 and p=0.05), DXA arm fat was higher (1568±801 vs 1285±534 g; p=0.047), and MRI abdominal fat volume was borderline (p=0.051).
  • Body fat percent was similar by DXA and BIA, and abdominal fat percentages (visceral, subcutaneous, liver) were similar by MRI/MRS. Fasting glucose, triglycerides, insulin, insulin resistance, HbA1c, cholesterol, liver transaminases, leptin, and adiponectin were similar; ferritin was higher in metformin offspring (52 (40–70) vs 40 (28–59) µg/L; p=0.009).

Methods

  • Longitudinal follow-up of offspring from the MiG randomized trial comparing metformin (±supplemental insulin) with insulin for GDM; Adelaide children assessed at ~7 years (n=109/181; metformin 58, insulin 51) and Auckland children at ~9 years (n=99/396; metformin 45, insulin 54), totaling 208 children (28% of the original cohort).
  • Assessments included anthropometry, bioimpedance analysis, DXA, MRI/MRS (Auckland n=92/99; Adelaide 12 later MRIs), and fasting bloods (Auckland n=82/99); assessors and data entry were blinded to maternal treatment allocation.
  • Between-group comparisons used Student’s t-test, Mann-Whitney U test, and Fisher’s exact test, with significance at 5%; the study had 80% power with 37 children per arm to detect a 2% difference in body fat percent.

Limitations

  • Stated: the overall follow-up rate was low (28% of the original cohort; 60.2% Adelaide, 25.1% Auckland), the followed populations differed from the initial MiG trial, and results may not apply to the total cohort; the sites were not combined; small subgroups limited adjustment for gender, ethnicity, and other factors; many variables were measured, risking a chance finding; pubertal status was by parental questionnaire.
  • Stated: Auckland mothers were not as well matched at baseline (higher BMI at enrollment in the metformin group, p=0.08; less weight gain during treatment, p=0.07) and the population was more heterogeneous; Adelaide maternal glucose control differed between treatment groups, unlike the overall cohort.
  • Evident from the text: the 9-year findings rely on site-specific analyses with modest MRI/MRS sample sizes, and the larger size in metformin-exposed Auckland children was partly borderline and attenuated after excluding children with early puberty (weight and DXA arm fat no longer different, both p=0.07).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2017-000456

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

4 Valid · 1 Not valid · 19 Not checked · 88 Own results and interpretations

53 more claims

Create a free account to see all 112 claims and to verify the 26 references still open.

See all claims — free account
  • Probably not a substantial claim. 30
  • It may state two separate claims as one. 35
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 28 references

Cited by

See all 305

Metadata

Authors
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M.
Affiliations
  • Auckland City Hospital (NZ)
  • Auckland University of Technology (NZ)
  • University of Auckland (NZ)
  • The University of Adelaide (AU)
  • Women's and Children's Hospital (AU)
Corresponding author
Rowan, Janet A
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2018-04
Volume
6
Issue
1
Pages
e000456
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2797222872
Cited by
305
References
28
Citations by year
2026: 19 · 2025: 42 · 2024: 30 · 2023: 41 · 2022: 37 · 2021: 37 · 2020: 46 · 2019: 33 · 2018: 18
FWCI
37.66
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Tuwhera (Auckland University of Technology) (submittedVersion, cc-by-nc)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
  • ResearchSpace (University of Auckland) (submittedVersion, cc-by-nc)
Funders
  • Auckland Medical Research Foundation
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
gestational diabetes mellitus, metformin, insulin therapy, offspring, abdominal fat, visceral adipose tissue, insulin resistance, metabolic outcomes, fetal programming, birth weight, childhood obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. https://app.cochat.ai/papers/10.1136/bmjdrc-2017-000456
The paper
Rowan, J. A., Rush, E. C., Plank, L. D., Lu, J., Obolonkin, V., Coat, S., & Hague, W. M. (2018). Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2017-000456

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.